US BROKER MOVES: WST upgraded at Barclays; FCEL upgraded at Canaccord

UPGRADES West Pharmaceutical Services (WST) Upgraded to Overweight at Barclays; PT USD 400 (prev. USD 310) PTC Therapeutics (PTCT) Upgraded to Buy at Citi; PT USD 108 (prev. USD 75) PAR Technology (PAR) Upgraded to Neutral at JPMorgan; PT USD 16 (prev. USD 12) FuelCell Energy (FCEL) Upgraded to Buy at Canaccord; PT USD 30 (prev. USD 12) Cleveland-Cliffs (CLF) Upgraded to Hold at GLJ Research Brady Corporation (BRC) Upgraded to Buy at Sidoti; PT USD 103 INITIATIONS Zymeworks (ZYME) Initiated at New Buy at Truist Securities; PT USD 28 VEON (VEON) Initiated at New Outperform at Northland; PT USD 70 Park Aerospace (PKE) Initiated at New Market Outperform at Citizens; PT USD 42 Magnite (MGNI) Initiated at New Buy at BTIG; PT USD 20 LSI Industries (LYTS) Initiated at New Outperform at Oppenheimer; PT USD 30 Grand Canyon Education (LOPE) Initiated at New Buy at Truist Securities; PT USD 200 Jazz Pharmaceuticals (JAZZ) Initiated at New Buy at Truist Securities; PT USD 256 International Flavors & Fragrances (IFF) Initiated at New Buy at Benchmark; PT USD 100 Barrick Gold (GOLD) Initiated at New Buy at Canaccord; PT USD 70 Precision BioSciences (DTIL) Initiated at New Outperform at Oppenheimer; PT USD 20 CF Industries (CF) Initiated at New Buy (1) at Huatai Financial; PT USD 195.72